FDA-Approved Peptides vs Research Peptides: What It Means for the RUO Industry
The distinction between an FDA-approved drug and a research-use-only peptide is more than a label. It shapes manufacturing, testing, and intended use.
The peptide industry sits at an unusual intersection. The same molecule may exist as an FDA-approved injectable drug, a compounded pharmacy preparation, and a research-use-only (RUO) reference standard — each with completely different regulatory frameworks.
Manufacturing standards
FDA-approved peptide drugs are produced under cGMP with full chain-of-custody documentation, validated processes, and stability programs spanning years. RUO peptides are produced for analytical and laboratory use, with batch testing but without the same regulatory overhead.
What RUO actually means
Research Use Only is a legal designation indicating the product is not intended for diagnostic, therapeutic, or human-consumption purposes. RUO peptides power academic and industrial research where a high-purity reference compound is needed without the cost and timeline of a clinical-grade material.
All content published in BuckLabs Research Notes is for informational and laboratory research purposes only. Nothing on this site constitutes medical advice or a recommendation for human use.